This federal contract award, with an ID of SPE2DB20D2104|SPE2DB21FT08D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a Pharmaceutical Prime Vendor to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
The contract has a ceiling value of $1,097.85 and is a Delivery Order with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for providing these critical medical commodities to the Department of Defense globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar pharmaceutical and medical supply requirements.
Generated 2/27/25, 10:12 AM